Specific inhibitor of mek-mediated cross-talk between erk and p38 mapk during differentiation of human osteosarcoma cells

Journal of Cell Communication and Signaling

Volumn 1, Issue 2, 2007, Pages 103-111

  Shimo, Tsuyoshi ^a   Matsumura, Shinsuke ^a   Ibaragi, Soichiro ^a   Isowa, Sachiko ^a   Kishimoto, Koji ^a   Mese, Hiroshi ^a   Nishiyama, Akiyoshi ^a   Sasaki, Akira ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Differentiaton; Extracellular signal regulated kinase; Mitogen activated protein kinase

Indexed keywords

EID: 50149094483     PISSN: 18739601     EISSN: 1873961X     Source Type: Journal    
DOI: 10.1007/s12079-007-0010-2     Document Type: Article

References (37)

1. Bebien M, Salinas S, Becamel C, Richard V, Linares L, Hipskind RA (2003) Immediate-early gene induction by the stresses aniso-mycin and arsenite in human osteosarcoma cells involves MAPK cascade signaling to Elk-1, CREB and SRF. Oncogene 22 (12):1836–1847
2. Bessey OA, Lowry OH, Brock MJ (1946) A method for the rapid determination of alkaline phosphatase with five cubic millimerters of serum. J Biol Chem 164:321–329
3. Bruserud O, Tronstad KJ, Berge R (2005) In vitro culture of human osteosarcoma cell lines: a comparison of functional characteristics for cell lines cultured in medium without and with fetal calf serum. J Cancer Res Clin Oncol 131(6):377–384
4. Cano E, Mahadevan LC (1995) Parallel signal processing among mammalian MAPKs. Trends Biochem Sci 20(3):117–122
5. Chaudhary LR, Avioli LV (1997) Activation of extracellular signal-regulated kinases 1 and 2 (ERK1 and ERK2) by FGF-2 and PDGF-BB in normal human osteoblastic and bone marrow stromal cells: differences in mobility and in-gel renaturation of ERK1 in human, rat, and mouse osteoblastic cells. Biochem Biophys Res Commun 238(1):134–139
6. Engelman JA, Lisanti MP, Scherer PE (1998) Specific inhibitors of p38 mitogen-activated protein kinase block 3T3-L1 adipogenesis. J Biol Chem 273(48):32111–32120
7. Goorin AM, Abelson HT, Frei E (1985) Osteosarcoma: fifteen years later. N Engl J Med 313(26):1637–1643
8. Guicheux J, Lemonnier J, Ghayor C, Suzuki A, Palmer G, Caverzasio J (2003) Activation of p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation. J Bone Miner Res 18(11):2060–2068
9. Hall-Jackson CA, Goedert M, Hedge P, Cohen P (1999) Effect of SB 203580 on the activity of c-Raf in vitro and in vivo. Oncogene 18 (12):2047–2054
10. Hotokezaka H, Sakai E, Kanaoka K, Saito K, Matsuo K, Kitaura H, Yoshida N, Nakayama K (2002) U0126 and PD98059, Specific inhibitors of MEK, accelerate differentiation of RAW264.7 cells into osteoclast-like cells. J Biol Chem 277(49):47366–47372
11. Hozumi M (1983) Fundamentals of chemotherapy of myeloid leukemia by induction of leukemia cell differentiation. Adv Cancer Res 38:121–169
12. Hu Y, Chan E, Wang SX, Li B (2003) Activation of p38 mitogen-activated protein kinase is required for osteoblast differentiation. Endocrinology 144(5):2068–2074
13. Huang W, Rudkin GH, Carlsen B, Ishida K, Ghasri P, Anvar B, Yamaguchi DT, Miller TA (2002) Overexpression of BMP-2 modulates morphology, growth, and gene expression in osteo-blastic cells. Exp Cell Res 274(2):226–234
14. Iwasaki S, Iguchi M, Watanabe K, Hoshino R, Tsujimoto M, Kohno M (1999) Specific activation of the p38 mitogen-activated protein kinase signaling pathway and induction of neurite outgrowth in PC12 cells by bone morphogenetic protein-2. J Biol Chem 274 (37):26503–26510
15. Juretic N, Santibanez JF, Hurtado C, Martinez J (2001) ERK 1,2 and p38 pathways are involved in the proliferative stimuli mediated by urokinase in osteoblastic SaOS-2 cell line. J Cell Biochem 83 (1):92–98
16. Kawamura H, Otsuka T, Tokuda H, Matsuno H, Niwa M, Matsui N, Uematsu T, Kozawa O (1999) Involvement of p42/p44 MAP kinase in endothelin-1-induced interleukin-6 synthesis in osteoblast-like cells. Bone 24(4):315–320
17. Kawane T, Horiuchi N (1999) Insulin-like growth factor I suppresses parathyroid hormone (PTH)/PTH-related protein receptor expression via a mitogen-activated protein kinase pathway in UMR-106 osteoblast-like cells. Endocrinology 140(2):871–879
18. Kyriakis JM, Banerjee P, Nikolakaki E, Dai T, Rubie EA, Ahmad MF, Avruch J, Woodgett JR (1994) The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369(6476):156–160
19. Lai CF, Chaudhary L, Fausto A, Halstead LR, Ory DS, Avioli LV, Cheng SL (2001) ERK is essential for growth, differentiation, integrin expression, and cell function in human osteoblastic cells. J Biol Chem 276(17):14443–14450
20. Lane JM, Hurson B, Boland PJ, Glasser DB (1986) Osteogenic sarcoma. Clin Orthop Relat Res 204:93–110
21. Li B, Ishii T, Tan CP, Soh JW, Goff SP (2002) Pathways of induction of peroxiredoxin I expression in osteoblasts: roles of p38 mitogen-activated protein kinase and protein kinase C. J Biol Chem 277(14):12418–12422
22. Liu Q, Hofmann PA (2004) Protein phosphatase 2A-mediated crosstalk between p38 MAPK and ERK in apoptosis of cardiac myocytes. Am J Physiol Heart Circ Physiol 286(6):2204–2212
23. Marshall CJ (1995) Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80(2):179–185
24. Matsuda N, Morita N, Matsuda K, Watanabe M (1998) Proliferation and differentiation of human osteoblastic cells associated with differential activation of MAP kinases in response to epidermal growth factor, hypoxia, and mechanical stress in vitro. Biochem Biophys Res Commun 249(2):350–354
25. New L, Li Y, Ge B, Zhong H, Mansbridge J, Liu K, Han J (2001) SB203580 promotes EGF-stimulated early morphological differentiation in PC12 cell through activating ERK pathway. J Cell Biochem 83(4):585–596
26. Raingeaud J, Gupta S, Rogers JS, Dickens M, Han J, Ulevitch RJ, Davis RJ (1995) Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 270 (13):7420–7426
27. Shimo T, Koyama E, Sugito H, Wu C, Shimo S, Pacifici M (2005) Retinoid signaling regulates CTGF expression in hypertrophic chondrocytes with differential involvement of MAP kinases. J Bone Miner Res 20(5):867–877
28. Suzuki A, Palmer G, Bonjour JP, Caverzasio J (2000) Stimulation of sodium-dependent phosphate transport and signaling mechanisms induced by basic fibroblast growth factor in MC3T3-E1 osteoblast-like cells. J Bone Miner Res 15(1):95–102
29. Suzuki A, Guicheux J, Palmer G, Miura Y, Oiso Y, Bonjour JP, Caverzasio J (2002) Evidence for a role of p38 MAP kinase in expression of alkaline phosphatase during osteoblastic cell differentiation. Bone 30(1):91–98
30. Tokuda H, Kozawa O, Harada A, Uematsu T (1999) p42/p44 mitogen-activated protein kinase activation is involved in prostaglandin F2alpha-induced interleukin-6 synthesis in osteoblasts. Cell Signal 11(5):325–330
31. Underwood DC, Osborn RR, Kotzer CJ, Adams JL, Lee JC, Webb EF, Carpenter DC, Bochnowicz S, Thomas HC, Hay DW, Griswold DE (2000) SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence. J Pharmacol Exp Ther 293(1): 281–288
32. Urist MR (1965) Bone: formation by autoinduction. Science 150 (698):893–899
33. Westermarck J, Li SP, Kallunki T, Han J, Kahari VM (2001) p38 mitogen-activated protein kinase-dependent activation of protein phosphatases 1 and 2A inhibits MEK1 and MEK2 activity and collagenase 1 (MMP-1) gene expression. Mol Cell Biol 21 (7):2373–2383
34. Williamson AJ, Dibling BC, Boyne JR, Selby P, Burchill SA (2004) Basic fibroblast growth factor-induced cell death is effected through sustained activation of p38MAPK and up-regulation of the death receptor p75NTR. J Biol Chem 279 (46):47912–47928
35. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270(5240):1326–1331
36. Yoshida Y, Tanaka S, Umemori H, Minowa O, Usui M, Ikematsu N, Hosoda E, Imamura T, Kuno J, Yamashita T, Miyazono K, Noda M, Noda T, Yamamoto T (2000) Negative regulation of BMP/Smad signaling by Tob in osteoblasts. Cell 103(7): 1085–1097
37. Yoshimichi G, Nakanishi T, Nishida T, Hattori T, Takano-Yamamoto T, Takigawa M (2001) CTGF/Hcs24 induces chondrocyte differentiation through a p38 mitogen-activated protein kinase (p38MAPK), and proliferation through a p44/42 MAPK/extra-cellular-signal regulated kinase (ERK). Eur J Biochem 268 (23):6058–6065